Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Ellis

Showing results (131-140 of 143) with videos related to

Pageof 15
Sort By:
The EMBO Journal|July 29, 2020
Glutamine deprivation alters the origin and function of cancer cell exosomesShih-Jung Fan, Benjamin Kroeger, Pauline P Marie, et al.
The New England Journal of Medicine|January 8, 2015
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancerSara M Tolaney, William T Barry, Chau T Dang, et al.
Breast Cancer Research and Treatment|April 21, 2019
Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)Jennifer R Bellon, Hao Guo, William T Barry, et al.
Plos Medicine|February 10, 2011
Setting research priorities to reduce almost one million deaths from birth asphyxia by 2015Joy E Lawn, Rajiv Bahl, Staffan Bergstrom, et al.
The Lancet. Oncology|May 9, 2016
Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trialIan E Krop, Ingrid A Mayer, Vinod Ganju, et al.
Journal of Proteome Research|October 29, 2014
Comprehensive quantitative analysis of ovarian and breast cancer tumor peptidomesZhe Xu, Chaochao Wu, Fang Xie, et al.
Therapeutic Advances in Medical Oncology|July 21, 2022
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancerValentina Hoyos, Spyridoula Vasileiou, Manik Kuvalekar, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 18, 2021
Potential of Magnetic Hyperthermia to Stimulate Localized Immune ActivationThomas J Carter, Giulia Agliardi, Fang-Yu Lin, et al.
The Oncologist|March 29, 2022
Breast Cancer Treatment Delay in SafetyNet Health Systems, Houston Versus Southeast BrazilMaryam Nemati Shafaee, Leonardo Roberto Silva, Susana Ramalho, et al.
Scientific Reports|October 29, 2017
Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington's disease miceMarie K Bondulich, Nelly Jolinon, Georgina F Osborne, et al.
Pageof 15

Showing results (131-140 of 143) with videos related to

Sort By:
Pageof 15
The EMBO Journal|July 29, 2020
Glutamine deprivation alters the origin and function of cancer cell exosomesShih-Jung Fan, Benjamin Kroeger, Pauline P Marie, et al.
The New England Journal of Medicine|January 8, 2015
Adjuvant paclitaxel and trastuzumab for node-negative, HER2-positive breast cancerSara M Tolaney, William T Barry, Chau T Dang, et al.
Breast Cancer Research and Treatment|April 21, 2019
Local-regional recurrence in women with small node-negative, HER2-positive breast cancer: results from a prospective multi-institutional study (the APT trial)Jennifer R Bellon, Hao Guo, William T Barry, et al.
Plos Medicine|February 10, 2011
Setting research priorities to reduce almost one million deaths from birth asphyxia by 2015Joy E Lawn, Rajiv Bahl, Staffan Bergstrom, et al.
The Lancet. Oncology|May 9, 2016
Pictilisib for oestrogen receptor-positive, aromatase inhibitor-resistant, advanced or metastatic breast cancer (FERGI): a randomised, double-blind, placebo-controlled, phase 2 trialIan E Krop, Ingrid A Mayer, Vinod Ganju, et al.
Journal of Proteome Research|October 29, 2014
Comprehensive quantitative analysis of ovarian and breast cancer tumor peptidomesZhe Xu, Chaochao Wu, Fang Xie, et al.
Therapeutic Advances in Medical Oncology|July 21, 2022
Multi-antigen-targeted T-cell therapy to treat patients with relapsed/refractory breast cancerValentina Hoyos, Spyridoula Vasileiou, Manik Kuvalekar, et al.
Small (Weinheim an Der Bergstrasse, Germany)|March 18, 2021
Potential of Magnetic Hyperthermia to Stimulate Localized Immune ActivationThomas J Carter, Giulia Agliardi, Fang-Yu Lin, et al.
The Oncologist|March 29, 2022
Breast Cancer Treatment Delay in SafetyNet Health Systems, Houston Versus Southeast BrazilMaryam Nemati Shafaee, Leonardo Roberto Silva, Susana Ramalho, et al.
Scientific Reports|October 29, 2017
Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington's disease miceMarie K Bondulich, Nelly Jolinon, Georgina F Osborne, et al.
Pageof 15